Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: A randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome

BACKGROUND: The Acute Respiratory Distress Syndrome (ARDS) is a common cause of respiratory failure in critically ill patients. Experimental studies suggest that treatment with beta agonists may be helpful in ARDS. The Beta Agonist Lung Injury TrIal (BALTI-2) is a multicentre, pragmatic, randomised,...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkins, Gavin D, Gates, Simon, Lamb, Sarah E, McCabe, Chris, Young, Duncan, Gao, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113985/
https://www.ncbi.nlm.nih.gov/pubmed/21554679
http://dx.doi.org/10.1186/1745-6215-12-113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113985/
https://www.ncbi.nlm.nih.gov/pubmed/21554679
http://dx.doi.org/10.1186/1745-6215-12-113

Ejemplares similares